Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058
about
HIV Epidemic in Asia: Implications for HIV Vaccine and Other Prevention Trials.Associations of place characteristics with HIV and HCV risk behaviors among racial/ethnic groups of people who inject drugs in the United States.HIV-1 and Hepatitis C virus selection bottleneck in Chinese people who inject drugs.Risky Sexual Behavior among Individuals receiving Buprenorphine/Naloxone Opiate Dependency Treatment: HIV Prevention Trials Network (HPTN) 058.Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?
P2860
Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Expanding substance use treatm ...... Prevention Trials Network 058
@ast
Expanding substance use treatm ...... Prevention Trials Network 058
@en
type
label
Expanding substance use treatm ...... Prevention Trials Network 058
@ast
Expanding substance use treatm ...... Prevention Trials Network 058
@en
prefLabel
Expanding substance use treatm ...... Prevention Trials Network 058
@ast
Expanding substance use treatm ...... Prevention Trials Network 058
@en
P2093
P2860
P50
P1476
Expanding substance use treatm ...... Prevention Trials Network 058
@en
P2093
Apinun Aramrattana
Bonnie J Dye
David N Burns
David S Metzger
Geetha Beauchamp
Gregory M Lucas
HPTN 058 Protocol Team
J Brooks Jackson
Katherine Shin
P2860
P304
P356
10.1097/QAI.0000000000000510
P407
P577
2015-04-01T00:00:00Z